Clinical Trials Browser

Phase 1/2 × INDUSTRY × Vemurafenib × Clear all

NCT01616199 2018-05-16

Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma

Phase 1/2 Terminated

Advanced BRAF-mutant Cancers